No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
No Data
Sector Update: Health Care Stocks Edge Higher in Afternoon Trading
HC Wainwright & Co. Reiterates Buy on Agenus, Maintains $40 Price Target
Agenus Analyst Ratings
Agenus Shares Rise 12% After Positive Data From Botensilimab/Balstilimab Study
Agenus Shares Rise After Trial Shows Tumor Reductions in Colon Cancer Patients
Agenus Announces Extended BOT/BAL Therapy Yields Pronounced Tumor Reductions In Colon Cancer; Results From Investigator-Sponsored Trial Presented At 2024 ESMO Gastrointestinal Cancers Congress